Filing Details

Accession Number:
0000899243-20-001322
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-16 16:20:57
Reporting Period:
2020-01-14
Accepted Time:
2020-01-16 16:20:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674365 Aptinyx Inc. APTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578965 Adam Koppel C/O Bain Capital Life Sciences
Investors Llc, 200 Clarendon Street
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-14 3,333,333 $3.00 5,558,425 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
Footnotes
  1. On January 14, 2020, the Bain Capital Life Sciences Fund, L.P. ("BCLS") and BCIP Life Sciences Associates, LP ("BCIP LS" and, collectively, the "Bain Life Sciences Entities") purchased, in the aggregate, 3,333,333 shares of Common Stock of the Issuer at a price of $3.00 per share, pursuant to an underwritten public offering.
  2. Represents shares of Common Stock held directly by the Bain Life Sciences Entities.
  3. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the ultimate general partner of BCLS and governs the investment strategy and decision making process with respect to investments held by BCIP LS. Dr. Koppel is a manager of BCLSI. By virtue of the relationships described in this footnote, Dr. Koppel may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Life Sciences Entities. Dr. Koppel disclaims beneficial ownership except to the extent of his pecuniary interest therein.